This article, lists the following clinical endpoints that all vaccines for COVID-19 should consider:
- SARS Cov-2 infection rate
- Asymptomatic infection rate
- Symptomatic infection (COVID-19) rate
- Non severe COVID-19 rate
- Severe COVID-19 rate
Link.
Link for the full text article.
doi: Link
To quote this article in bibliography:
Devan V. Mehrotra, Devan V, Holly E. Janes, Thomas R. Fleming, et al. “Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials." Annals of Internal Medicine (Epub ahead of print 22 October 2020). doi:10.7326/M20-6169